Resources
Publications  Keetharuth A.D., Taylor Buck E., Conway K., Acquadro C., Connell J., Barkham M., et al. International Journal of Environmental and Research and Public Health The  Connell J, Carlton, J., Grundy, A., Taylor Buck, E., Keetharuth,A. , Ricketts, T.,Barkham, M., Rose, D., Robotham, D., Rose, D., Brazier, J. Quality of Life Research 2018;27(7):1893–902. Keetharuth, A., Brazier, J., Connell, J., Carlton, J., Taylor Buck, E., Ricketts, T., & Barkham, M. (2017). Policy Research Unit in Economic Evaluation of Health and Care Interventions. Universities of Sheffield and York. EEPRU Research Report 050. Which costs matter? Costs included in economic evaluation and their impact on decision uncertainty for stable coronary artery disease LomasJ., Asaria M., Bojke L., Gale C.P., Richardson G., Walker S., British Medical Journal Duarte A., Bojke C., Cayton W., Salawu A., Case B., Bojke L., Richardson G.  Experi  Brazier J., Rowen D., Karimi M., Peasgood T., Tsuchiya A., Ratcliffe J. European Journal of Health Economics Bojke L., Manca, A., Miqdad, A., Mahan R., Palmer S., Ren, S,. Pharmacoeconomics. Recovering Quality of Life (ReQoL): a new generic self-reported outcome measure for use with people experiencing mental health difficulties Keetharuth, A., Brazier, J., Connell, J.B.Bjorner, J., Carlton, J., Taylor Buck, E., Ricketts, T., McKendrick K., Browne J., Croudace T. & Barkham, M. (2017) on behalf of the ReQoL Scientific Group. British Journal of Psychiatry (2018). Quantifying the relationship between capability and health in older people: can’t map, won’t map Franklin M, Payne K, Elliott R A. Medical Decision Making Online (2017). Evaluating the cost-effectiveness of biologic treatments for psoriatic arthritis: can we make better use of patient data registries? Patton T, Bojke L, Walton M. et al. Clin Rheumatol (2017) 36: 1803. Informing reimbursement decisions using cost-effectiveness modelling: a guide to the process of generating elicited priors to capture model uncertainties Bojke L, Grigore B, Jankovic D, Peters J, Soares M, Stein K. PharmacoEconomics (2017) 35: 867. How to appropriately extrapolate costs and utilities in cost-effectiveness analysis? Bojke L, Manca A, Asaria M, Mahan R, Palmer S, Ren S. PharmacoEconomics (2017) 35: 767. The Cost-Effectiveness of Population Health Checks: have the NHS Health Checks been unfairly maligned? Hinde S, Bojke L, Richardson G, Retat L, Webber L. J Public Health (2017) 25: 425. Designing and undertaking a health economics study of digital health interventions. McNamee P, Murray E, Kelly M P, Bojke L, Chilcott J, Fischer A, West R and Yardley L. American Journal of Preventive Medicine. 2016 Nov 30;51(5):852-60. A pharmacoeconomic approach to assessing the costs and benefits of air quality interventions that improve health: a case study. Lomas J, Schmitt L, Jones S, McGeorge M, Bates E, Holland M, Cooper D, Crowther R, Ashmore M, Rueda D R, Weatherly H, Richardson G, Bojke L. BMJ Open 2016;6:e010686. Health, health-related quality of life, and quality of life: what is the difference? Karimi M, Brazier J. PharmacoEconomics (2016) 34: 645.  Prady S L, Bloor K, Bradshaw J, Tunstall H, Petherick E S, Pickett K E. Journal of Social Policy and Society Volume 15, Issue 4 October 2016, pp. 513-535 Preschoolers in the Playground: a pilot cluster randomised controlled trial of a physical activity intervention for children aged 18 months to 4 years. Barber S, Akhtar S, Jackson C, Bingham D, Hewitt C, Routen A, et al.Preschoolers in the Playground: a pilot cluster randomised controlled trial of a physical activity intervention for children aged 18 months to 4 years. Public Health Res 2015;3(5) Systematic review of the economic evidence on home visitation programmes for vulnerable pregnant women Stamuli E, Richardson G, Duffy S, Robling M, Hood K. Systematic review of the economic evidence on home visitation programmes for vulnerable pregnant women. British medical bulletin. 2015 Sep 1;115(1):19-44. Examining the incremental impact of long-standing health conditions on subjective well-being alongside the EQ-5D. Wu M, Brazier J, Relton C, Cooper C, Smith C, Blackburn J. Examining the incremental impact of long-standing health conditions on subjective well-being alongside the EQ-5D. Health and quality of life outcomes. 2014 Apr 29;12(1):1 Quality of life impact of mental health conditions in England: results from the adult psychiatric morbidity surveys Roberts J, Lenton P, Keetharuth AD, Brazier J. Quality of life impact of mental health conditions in England: results from the adult psychiatric morbidity surveys. Health and quality of life outcomes. 2014 Jan 14;12(1):1. Related publications Improving Cross-Sector Comparisons: Going Beyond the Health-Related QALY Brazier J, Tsuchiya A. Applied health economics and health policy. 2015 Dec 1;13(6):557-65 |
